Transformation of brain myeloid cell populations by SIV in rhesus macaques revealed by multiomics
Concurrent TB and HIV therapies effectively control clinical reactivation of TB during co-infection but fail to eliminate chronic immune activation
Alveolar macrophages from persons with HIV mount impaired TNF signaling networks to M. tuberculosis infection.
Phosphorylation-mediated conformational switch regulates human SLFN11
CCR5 Decorated Rilpivirine Lipid Nanoparticles Build Myeloid Drug Depots Which Sustains Antiretroviral Activities
The molecular immune modulator adenosine deaminase-1 enhances HIV specific humoral and cellular responses to a native-like HIV envelope trimer DNA vaccine
In vivo affinity maturation of the HIV-1 Env-binding domain of CD4
Dual blockade of IL-10 and PD-1 leads to control of SIV viral rebound following analytical treatment interruption.
Early antiretroviral therapy favors post-treatment SIV control associated with expansion of enhanced memory CD8+ T cells. pVISCONTI study
Vaccination with intravenous BCG protects macaques with pre-existing SIV infection from tuberculosis